A Study of the Safety and Efficacy of Topiramate in the Treatment of Obese, Type 2 Diabetes Patients on a Controlled Diet
PHASE3CompletedINTERVENTIONAL
Enrollment
541
Participants
Timeline
Start Date
January 31, 2001
Study Completion Date
May 31, 2002
Conditions
ObesityDiabetes Mellitus, Type 2Diabetes Mellitus, Adult-Onset
Interventions
DRUG
topiramate
All Listed Sponsors
lead
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
INDUSTRY
NCT00231530 - A Study of the Safety and Efficacy of Topiramate in the Treatment of Obese, Type 2 Diabetes Patients on a Controlled Diet | Biotech Hunter | Biotech Hunter